| 000 | 01867 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514051155.0 | ||
| 264 | 0 | _c20030408 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0704938 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakahashi, Ryosuke | |
| 245 | 0 | 0 |
_aThe mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cNov 2002 |
||
| 300 |
_a845-54 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGlycopeptides _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNeurokinin A _xpharmacology |
| 650 | 0 | 4 |
_aNeurokinin B _xpharmacology |
| 650 | 0 | 4 | _aNeurokinin-1 Receptor Antagonists |
| 650 | 0 | 4 |
_aPenis _xdrug effects |
| 650 | 0 | 4 |
_aPermeability _xdrug effects |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aQuinuclidines _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSubstance P _xpharmacology |
| 650 | 0 | 4 |
_aTachykinins _xpharmacology |
| 650 | 0 | 4 |
_aType C Phospholipases _xpharmacology |
| 700 | 1 | _aNishimura, Junji | |
| 700 | 1 | _aHirano, Katsuya | |
| 700 | 1 | _aNaito, Seiji | |
| 700 | 1 | _aKanaide, Hideo | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 137 _gno. 6 _gp. 845-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0704938 _zAvailable from publisher's website |
| 999 |
_c12219489 _d12219489 |
||